Dermatology Ltd

CLIA Laboratory Citation Details

3
Total Citations
12
Total Deficiencyies
6
Unique D-Tags
CMS Certification Number 39D0915347
Address 101 Chesley Dr Ste 100 Georgetown Bldg, Media, PA, 19063
City Media
State PA
Zip Code19063
Phone(610) 566-7111

Citation History (3 surveys)

Survey - October 22, 2024

Survey Type: Standard

Survey Event ID: HRXR11

Deficiency Tags: D5413 D5403 D5601 D5413 D5601

Summary:

Summary Statement of Deficiencies D5403 PROCEDURE MANUAL CFR(s): 493.1251(b) The procedure manual must include the following when applicable to the test procedure: (1) Requirements for patient preparation; specimen collection, labeling, storage, preservation, transportation, processing, and referral; and criteria for specimen acceptability and rejection as described in 493.1242. (2) Microscopic examination, including the detection of inadequately prepared slides. (3) Step-by-step performance of the procedure, including test calculations and interpretation of results. (4) Preparation of slides, solutions, calibrators, controls, reagents, stains, and other materials used in testing. (5) Calibration and calibration verification procedures. (6) The reportable range for test results for the test system as established or verified in 493.1253. (7) Control procedures. (8)

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - February 27, 2023

Survey Type: Standard

Survey Event ID: RCKS11

Deficiency Tags: D5217

Summary:

Summary Statement of Deficiencies D5217 EVALUATION OF PROFICIENCY TESTING PERFORMANCE CFR(s): 493.1236(c)(1) At least twice annually, the laboratory must verify the accuracy of any test or procedure it performs that is not included in subpart I of this part. This STANDARD is not met as evidenced by: Based on the review of the laboratory's procedure manual, peer review records, and interview with the Testing Personnel #12 and Laboratory Director, the laboratory failed to verify the accuracy of the microscopic examinations for histopathology (Mohs Surgery), at least twice annually as required for tests not included in subpart I in 2021 and 2022. Findings include: 1. The laboratory's Proficiency Testing policy (Lab Policy #17) stated that "Every year, a random sample of five patients and their related slides will be selected from all microscopic slides prepared within the year for each Dermatology Surgeon." 2. On the day of survey, 02/27/2023 at 10:04 am, review of Mohs surgery peer review records revealed that evaluation and verification activity was performed for the microscopic examinations for histopathology (Mohs Surgery) once in 2021 (November 03, 2021) and in 2022 (December 21, 2022) instead of the twice annually as required. 3. The laboratory performed 4561 and 5816 microscopic examinations for histopathology (Mohs Surgery) in 2021 and 2022, respectively. 4. Testing Personnel #12 confirmed when interviewed on 02/27/2023 around 10:30 am that evaluation and verification activity was performed for histopathology (Mohs Surgery) once in 2021 and 2022. The Laboratory Director also confirmed the findings above on 02/27/2023 around 11:30 am. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 1 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - September 25, 2018

Survey Type: Standard

Survey Event ID: 4TJN11

Deficiency Tags: D5413 D6094 D5413 D5415 D5415 D6094

Summary:

Summary Statement of Deficiencies D5413 TEST SYSTEMS, EQUIPMENT, INSTRUMENTS, REAGENT CFR(s): 493.1252(b) The laboratory must define criteria for those conditions that are essential for proper storage of reagents and specimens, accurate and reliable test system operation, and test result reporting. The criteria must be consistent with the manufacturer's instructions, if provided. These conditions must be monitored and documented and, if applicable, include the following: (1) Water quality. (2) Temperature. (3) Humidity. (4) Protection of equipment and instruments from fluctuations and interruptions in electrical current that adversely affect patient test results and test reports. This STANDARD is not met as evidenced by: Based on review of Mohs Laboratory temperature logs and interview with testing personnel (TP) #11 and 12, the laboratory failed to define acceptable range conditions that are essential for the operation of 4 of 4 Leica CM 1850 Cryostats from 2017 to the date of survey. Findings include: 1. The Leica CM1850 Cryostat Manual, under the technical Date section states, "Operating temperature range (ambient temperature): 18 degrees Celsius to 35 degrees Celsius. All specifications related to temperatures of the cooling unit are valid only for an ambient temperature of 22 degrees Celsius and a relative humidity of no more than 60%!". Cryochamber temperature range: 0 degrees Celsius to -35 degrees Celsius. 2. On the day of survey, 09/25/2018, review of Mohs Laboratory temperature logs revealed that the laboratory does not define ranges for room temperate, 4 of 4 cryostat chambers and room humidity. 3. TP # 11 and TP #12 confirmed the findings above on 09/25/2018 around 2:30 pm. D5415 TEST SYSTEMS, EQUIPMENT, INSTRUMENTS, REAGENT CFR(s): 493.1252(c) Reagents, solutions, culture media, control materials, calibration materials, and other Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- supplies, as appropriate, must be labeled to indicate the following: (1) Identity and when significant, titer, strength or concentration. (2) Storage requirements. (3) Preparation and expiration dates. (4) Other pertinent information required for proper use. This STANDARD is not met as evidenced by: Based on tour of the MOHS laboratory, observation of Tissue Marking Dye bottles, interview with Testing Personnel (TP) #11 and 12, the laboratory failed to label 3 of 3 bottles and 9 of 9 aliquots of Davidson Marking System Dyes with open and expiration dates from 2017 to the date of survey. Findings Include: 1. On the day of survey, 09/25/2018, while on tour of the MOHS laboratory, it was discovered that 3 of 3 bottles of Davidson Marking Systems Dye were without open and expiration dates and 9 of 9 aliquots of Davidson Marking Systems Dyes were observed without idenifcation of dyes and expiration dates. 2. TP #11 and TP#12 confirmed the findings above on 09/25/2018 around 2:45 pm. D6094 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1445(e)(5) The laboratory director must ensure that the quality assessment programs are established and maintained to assure the quality of laboratory services provided and to identify failures in quality as they occur. This STANDARD is not met as evidenced by: Based on, the review of MOHS laboratory quality assessment procedure and interview with Testing personnel (TP) #11 and #12, the laboratory failed to ensure that quality assessment programs are maintained and documented to assure the quality of the Mohs laboratory from 2017 to the date of survey. Findings: 1. At the time of survey, 09/25/2018, the MOHS laboratory could not provide documentation of quality assessment activities performed form 2017 to the date of survey. 2. Review of the procedure manual revealed, that the quality assessment procedure address personnel competency assessment and not the overall quality of the laboratory. 3. TP # 11 and TP #12 confirmed the findings above on 09/25/2018 around 03:00 pm. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access